Navigation
Home covid-19 news Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19

Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19

Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19
April 20, 2020 Excelsio Media
Share To:
Swiss drugmaker Novartis gets go-ahead from U.S. regulators to conduct tests of malaria drug against COVID-19.

Share
Tags covid-19 news

Excelsio Media

EXCELSIO Media, is an independent source of news and information.

View Profile
covid-19 news

Post A Comment:

0 comments:

Leave a comment. Thanks!

Subscribe to: Post Comments (Atom)